Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
15.06
-0.01 (-0.07%)
At close: May 23, 2025, 3:59 PM
15.01
-0.33%
After-hours: May 23, 2025, 04:20 PM EDT
-0.07% (1D)
| Bid | 14.4 |
| Market Cap | 908.93M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -208.93M |
| EPS (ttm) | -3.06 |
| PE Ratio (ttm) | -4.92 |
| Forward PE | -4.57 |
| Analyst | Buy |
| Ask | 17.07 |
| Volume | 145,183 |
| Avg. Volume (20D) | 685,871 |
| Open | 14.68 |
| Previous Close | 15.07 |
| Day's Range | 14.78 - 15.12 |
| 52-Week Range | 10.91 - 40.26 |
| Beta | 2.79 |
About SYRE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SYRE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SYRE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+9.64%
Spyre Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
6 months ago
-8.97%
Spyre Therapeutics shares are trading lower. The company announced interim Phase 1 data from its first-in-human trial of SPY001.
